USPTO serial 79159238
PHARMINVENT
Reviewed by CopyMark Law Group
Reg. 4883525Status 404
- Filing date
- Status date
- Registration date
- Jan 12, 2016
- Examiner
- SEVERSON, JUSTIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHARMINVENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
European Pharminvent Services, s.r.o.
CZ-130 00 Praha 3, CZ
Other trademarks owned by European Pharminvent Services, s.r.o.
European Pharminvent Services, s.r.o.
CZ-130 00 Praha 3, CZ
Other trademarks owned by European Pharminvent Services, s.r.o.
European Pharminvent Services, s.r.o.
CZ-130 00 Praha 3, CZ
Other trademarks owned by European Pharminvent Services, s.r.o.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gloria Tsui-Yip
Gloria Tsui-Yip Miskin & Tsui-Yip, LLP1350 BroadwaySuite 802New York, NY 10018Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Bacteriological consultation and research; calibration services relating to medical apparatus; conducting clinical trials and early evaluations for others in the field of new pharmaceuticals; consultancy pertaining to pharmacology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials, services for assessing the efficiency of veterinary drugs; services for assessing the efficiency of pharmaceuticals; consulting in the field of pharmacovigilance, namely, providing analysis of data obtained from pharmaceutical clinical trial research; services for regulatory science in the field of pharmaceuticals and clinical trials; consulting services in the field of marketing authorization of medicinal products; pharmaceutical research services, namely, conducting audits in the field of pharmacovigilance | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by European Pharminvent Services, s.r.o.
- Other trademarks owned by European Pharminvent Services, s.r.o.
- Other trademarks owned by European Pharminvent Services, s.r.o.
- Other trademarks in Class 042
- Similar marks named PHARMINVENT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Mar 21, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 29, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| May 10, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 10, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 29, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 29, 2022 | C71T | CANCELLED SECTION 71 | — |
| Jan 12, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 8, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 14, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 14, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 12, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 21, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 12, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 27, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 27, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 7, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 23, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 17, 2015 | ALIE | ASSIGNED TO LIE | — |
| Aug 24, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 31, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 26, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 26, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 27, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 6, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 5, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 4, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 29, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |